Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization